Immunovant Inc. Common Stock vs Super Group (SGHC) Limited Ordinary Shares — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Super Group (SGHC) Limited Ordinary Shares trades at $11.59 (market cap $5.77B). The key difference: Immunovant Inc. Common Stock and Super Group (SGHC) Limited Ordinary Shares are close in size by market cap, and Super Group (SGHC) Limited Ordinary Shares pays a 1.76% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Super Group (SGHC) Limited Ordinary Shares for 0 Days on average.
| IMVT | SGHC | |
|---|---|---|
Market Cap | $6.62B | $5.77B |
Volume | 1,131,364 | 2,136,691 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $15.59 |
52-Week Low | $17.03 | $8.52 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $5.31B |
Dividend Yield | — | 1.76% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.
Read more on SGHC →